Douglas B. Evans, MD

Publications

• Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy.

  (Ward EP, Vincent-Sheldon S, Tolat P, Kulkarni N, Aldakkak M, Budithi R, Clarke CN, Tsai S, Evans DB, Christians KK.) Surgery. 2024 May;175(5):1386-1393 PMID: 38413302 SCOPUS ID: 2-s2.0-85186348752 02/28/2024

• Surgeon compensation in academic medicine

  (Evans DB, Mayer JB.) Surgery (United States). 2024 SCOPUS ID: 2-s2.0-85186660567 01/01/2024

• Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.

  (de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA.) Cancer Med. 2023 Dec 22;13(1) PMID: 38140796 PMCID: PMC10807686 SCOPUS ID: 2-s2.0-85180644976 12/23/2023

• Going for Broke: The Impact of Cost of Living on Surgery Resident Stipend Value.

  (Drezdzon MK, Cowley NJ, Sweeney DP, Peterson CY, Ridolfi TJ, Ludwig KA, Evans DB, Calata JF.) Ann Surg. 2023 Dec 01;278(6):1053-1059 PMID: 37226808 SCOPUS ID: 2-s2.0-85176509408 05/25/2023

• Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer.

  (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S.) Ann Surg. 2023 Dec 01;278(6):e1224-e1231 PMID: 37078282 SCOPUS ID: 2-s2.0-85176508848 04/20/2023

• Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice.

  (Merrill JR, Flitcroft MA, Miller T, Beichner B, Clarke CN, Maduekwe UN, Wang TS, Dream S, Christians KK, Gamblin TC, Evans DB, Kothari AN.) J Surg Res. 2023 Aug;288:269-274 PMID: 37037166 SCOPUS ID: 2-s2.0-85151667989 04/11/2023

• Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.

  (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S.) J Surg Oncol. 2023 Jul;128(1):41-50 PMID: 36960919 SCOPUS ID: 2-s2.0-85152449940 03/25/2023

• Constitutional mosaicism for a pathogenic variant in MEN1 associated with multiple endocrine neoplasia type I syndrome.

  (Jacquart A, Schilter KF, Udani R, Evans D, Carroll TB, Reddi HV.) Clin Genet. 2023 Jul;104(1):139-141 PMID: 36840469 SCOPUS ID: 2-s2.0-85149270134 02/26/2023

• ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

  (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3022 PMID: 36877324 SCOPUS ID: 2-s2.0-85152164746 03/07/2023

• CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

  (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3013-3021 PMID: 36788189 SCOPUS ID: 2-s2.0-85147934173 02/15/2023

• Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery.

  (Verhagen NB, Koerber NK, Szabo A, Taylor B, Wainaina JN, Evans DB, Kothari AN, N3C Consortium.) Ann Surg Oncol. 2023 Mar;30(3):1305-1308 PMID: 36479662 PMCID: PMC9734328 SCOPUS ID: 2-s2.0-85143492422 12/09/2022

• Older Patients With Asymptomatic Primary Hyperparathyroidism: Should Criteria for Surgery Be Expanded?

  (Bartz-Kurycki MA, Dream S, Yen TW, Doffek K, Shaker J, Evans DB, Wang TS.) Journal of the Endocrine Society. 1 September 2023;7(9) SCOPUS ID: 2-s2.0-85169911881 09/01/2023